Clinical Trial Update: HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating HCV-RNA kinetics in patients with hepatocellular carcinoma treated with sorafenib; the study was terminated and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Cancer | Phase 4 | Status: TERMINATED | Results posted: 2017-03-13